Abstract:Background: Hepatitis C virus (HCV) infection causes slowly progressive liver disease. Therefore, the full impact of HCV infection after transplantation may require 5-10 years of follow-up. Methods: We have previously reported the effect of HCV infection, acquired from the donor (study 1) or acquired before transplantation (study 2), on the incidence of liver disease, and on patient and graft survival with a median follow-up of 3-5 years. In study 1, we compared 24 recipients of organs from donors who were positive to antibody to HCV (anti-HCV) to 74 recipients of organs from anti-HCV-negative donors. In study 2, we compared 23 anti-HCV-positive recipients to 80 anti-HCV-negative recipients of kidneys from anti-HCV-negative donors. In this report, we extend the median follow-up period for patient and graft survival to 6-7 years, and discuss the implications of our finding on policies for organ procurement. Results: In study 2, after extended follow-up, there continued to be no significant difference between groups with respect to graft loss, but mortality remained significantly higher among recipients with anti-HCV before transplantation. Compared with recipients without anti-HCV before transplantation, the relative risk of graft loss among recipients with anti-HCV before transplantation was 1.30 (0.66-2.58), the relative risk of death was 2.60 (1.15-5.90), and the relative risk of death due to sepsis was 6.30 (1.99-20). In study 1, after extended follow-up, there continued to be no significant differences between groups, with respect to graft loss or death. Compared with recipients of organs from anti-HCV-negative donors, the relative risk of graft loss among recipients of organs from anti-HCV-positive donors was 0.95 (0.54-1.67), and the relative risk of death was 1.00 (0.49-2.02). Conclusions: The two studies presented in this report provide an apparent paradox, with respect to the impact of HCV infection acquired at the time of transplantation versus before transplantation on posttransplantation clinical outcomes. However, the increased mortality among recipients who acquired HCV infection before transplantation, but not among recipients who acquired HCV at the time of transplantation, could be explained by the longer duration of HCV infection in the former group. These findings are consistent with the known slowly progressive nature of HCV infection. However, in the absence of definitive evidence for an adverse effect on patient or graft survival, we believe that the decision to accept a kidney from an anti-HCV-positive donor should be made by the patient, after discussion with the treating physician.

No Improvement in Long-Term Liver Transplant Graft Survival in the Last Decade: an Analysis of the UNOS Data

Improved Long-Term Graft Survival After Deceased Donor Kidney Transplantation in the United States From 1988 to 2007

No Improvement in Intention-to-treat Survival and Increasing Liver Nonutilization Rate During the MELD Era

Short-term and long-term outcomes of liver transplantation using moderately and severely steatotic donor livers: A systematic review.

The Influence of Infection of Hepatitis B and Hepatitis C Virus on the Long-Term Survival of the Renal Transplantation Recipients

Life Expectancy after Liver Transplantation for Non-Cirrhotic Hepatocellular Carcinoma

Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement

Outcome statistics of renal transplants with an emphasis on long‐term survival

Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment

Analysis of Very Long-Term Survivors after Liver Transplantation

Liver Grafts for Transplantation from Donors with Diabetes: an Analysis of the Scientific Registry of Transplant Recipients Database

Temporal evolution of living donor liver transplantation survival - A UNOS registry study

[Analysis of 565 Cases of Liver Transplantation at a Single Transplantation Center].

The Lower Survival in Patients With Alcoholism and Hepatitis C Continues in the DAA Era

Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation: 15-year analysis of recent UNOS database

Intent-to-treat Analysis of Liver Transplant for Hepatocellular Carcinoma in the MELD Era: Impact of Hepatitis C and Advanced Status.

Survival In Liver Transplant Recipients With Hepatitis B- Or Hepatitis C-Associated Hepatocellular Carcinoma: The Chinese Experience From 1999 To 2010

Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database

553 LIVER TRANSPLANTATION FOR HEPATITIS B VIRUS BACKGROUND HEPATOCELLULAR CARCINOMA: A PROSPECTIVE STUDY COMPARING MILAN AND HANGZHOU CRITERIA AT A SINGLE TRANSPLANTATION CENTER IN CHINA

Long-term outcomes after curative resection of HCV-positive versus non-hepatitis related hepatocellular carcinoma: an international multi-institutional analysis

Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients